GeneDx (WGS) News Today $69.38 -1.66 (-2.34%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period GeneDx Holdings Corp. (NASDAQ:WGS) Major Shareholder School Of Medicine At Mo Icahn Sells 126,782 SharesNovember 21 at 4:05 AM | americanbankingnews.comThompson Davis & CO. Inc. Sells 7,244 Shares of GeneDx Holdings Corp. (NASDAQ:WGS)Thompson Davis & CO. Inc. cut its stake in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 33.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,600 shares of the company's stock after selling 7,244 sharesNovember 20 at 6:27 AM | marketbeat.comSchool Of Medicine At Mo Icahn Sells 20,359 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) StockNovember 20 at 5:31 AM | insidertrades.comInsider Selling: GeneDx Holdings Corp. (NASDAQ:WGS) CEO Sells 22,307 Shares of StockNovember 20 at 4:09 AM | americanbankingnews.comKatherine Stueland Sells 22,307 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) StockGeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) CEO Katherine Stueland sold 22,307 shares of the firm's stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $70.34, for a total transaction of $1,569,074.38. Following the completion of the transaction, the chief executive officer now directly owns 60,011 shares in the company, valued at approximately $4,221,173.74. The trade was a 27.10 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.November 20 at 4:06 AM | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) CEO Sells $1,628,651.84 in StockGeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) CEO Katherine Stueland sold 23,108 shares of the company's stock in a transaction on Friday, November 15th. The shares were sold at an average price of $70.48, for a total transaction of $1,628,651.84. Following the sale, the chief executive officer now owns 82,318 shares of the company's stock, valued at $5,801,772.64. The trade was a 21.92 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.November 20 at 4:06 AM | marketbeat.comRoyce & Associates LP Acquires New Shares in GeneDx Holdings Corp. (NASDAQ:WGS)Royce & Associates LP bought a new position in shares of GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 28,293 shares of the company's stock, valued at approximately $1,201,0November 20 at 3:59 AM | marketbeat.comGeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx DiscoverNovember 19 at 11:58 AM | stockhouse.comGeneDx appoints Heidi Chen as chief legal officerNovember 19 at 7:47 AM | markets.businessinsider.comGeneDx (NASDAQ:WGS) Shares Gap Down - Here's What HappenedGeneDx (NASDAQ:WGS) Shares Gap Down - Here's WhyNovember 18 at 1:17 PM | marketbeat.comGeneDx Announces Heidi Chen as Chief Legal Officer and Corporate SecretaryNovember 18 at 9:08 AM | businesswire.comMeet the Healthcare Stock That Produced Nvidia-Sized Gains in Less Than a YearNovember 16, 2024 | fool.comAnalysts Set GeneDx Holdings Corp. (NASDAQ:WGS) Target Price at $59.33November 15, 2024 | americanbankingnews.com40,573 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Acquired by Chartwell Investment Partners LLCChartwell Investment Partners LLC acquired a new position in shares of GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund acquired 40,573 shares of the company's stock, valued at approximately $1,722,000. Chartwell InvNovember 13, 2024 | marketbeat.com36,615 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Bought by Lisanti Capital Growth LLCLisanti Capital Growth LLC acquired a new position in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 36,615 shares of the company's stock, valued at approximately $1,554,00November 11, 2024 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) Receives Average Recommendation of "Moderate Buy" from BrokeragesGeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the six ratings firms that are covering the company, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation and three have issued a buy recomNovember 10, 2024 | marketbeat.comNew GeneDx Study Reveals Racial Disparities in Genetic Diagnosis Due to Systemic Barriers, Not Diagnostic YieldsNovember 7, 2024 | businesswire.comGeneDx Holdings Corp. (NASDAQ:WGS) Major Shareholder Sells $64,935,000.00 in StockNovember 5, 2024 | insidertrades.comInsider Selling: GeneDx Holdings Corp. (NASDAQ:WGS) Major Shareholder Sells 865,800 Shares of StockGeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) major shareholder School Of Medicine At Mo Icahn sold 865,800 shares of the firm's stock in a transaction on Thursday, October 31st. The stock was sold at an average price of $75.00, for a total transaction of $64,935,000.00. Following the transaction, the insider now directly owns 2,866,833 shares of the company's stock, valued at approximately $215,012,475. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Large shareholders that own at least 10% of a company's stock are required to disclose their transactions with the SEC.November 4, 2024 | marketbeat.comGeneDx to Highlight Key Research Findings at American Society of Human Genetics (ASHG) Annual MeetingNovember 4, 2024 | businesswire.comGeneDx 865K share Block Trade; price range $77.00-$80.00November 2, 2024 | markets.businessinsider.comGeneDx 865K share Block Trade priced at $77.00November 1, 2024 | markets.businessinsider.comGeneDx (NASDAQ:WGS) Releases Quarterly Earnings Results, Beats Expectations By $0.25 EPSGeneDx (NASDAQ:WGS - Get Free Report) posted its quarterly earnings data on Tuesday. The company reported $0.04 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.21) by $0.25. The firm had revenue of $76.90 million for the quarter, compared to the consensus estimate of $64.98 million. GeneDx had a negative net margin of 31.25% and a negative return on equity of 13.35%. The business's revenue for the quarter was up 44.3% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.82) EPS.November 1, 2024 | marketbeat.comGeneDx (NASDAQ:WGS) Shares Gap Down After Insider SellingGeneDx (NASDAQ:WGS) Shares Gap Down Following Insider SellingNovember 1, 2024 | marketbeat.comKevin Feeley Sells 274 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) StockNovember 1, 2024 | insidertrades.comPalumbo Wealth Management LLC Takes $287,000 Position in GeneDx Holdings Corp. (NASDAQ:WGS)Palumbo Wealth Management LLC purchased a new position in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 6,761 shares of the company's stock, valued at approximately $287,00October 31, 2024 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) Q3 2024 Earnings Call TranscriptOctober 31, 2024 | msn.comGeneDx Holdings: Phenomenal Gains, More Upside Potential In Medium TermOctober 30, 2024 | seekingalpha.comGeneDx (NASDAQ:WGS) Given New $70.00 Price Target at The Goldman Sachs GroupThe Goldman Sachs Group upped their price objective on GeneDx from $54.00 to $70.00 and gave the stock a "neutral" rating in a research report on Wednesday.October 30, 2024 | marketbeat.comGeneDx price target raised to $95 from $70 at Craig-HallumOctober 30, 2024 | markets.businessinsider.comGeneDx price target raised to $95 from $45 at BTIGOctober 30, 2024 | markets.businessinsider.comGeneDx Holdings Corp (WGS) Q3 2024 Earnings Call Highlights: Record Revenue Growth and First ...October 30, 2024 | finance.yahoo.comGeneDx price target raised to $75 from $34 at Wells FargoOctober 29, 2024 | markets.businessinsider.comGeneDx Holdings: Impressive Growth Undermined by High Valuation Leading to Hold RatingOctober 29, 2024 | markets.businessinsider.comGeneDx Reports Third Quarter 2024 Financial Results and Business HighlightsOctober 29, 2024 | finance.yahoo.comGeneDx Stock Up Over 33% On Increased Annual Revenue Above View- UpdateOctober 29, 2024 | markets.businessinsider.comGeneDx climbs after profitability milestone in Q3October 29, 2024 | msn.comGenetic Testing Firm GeneDx Reports Narrower Q3 Loss As Revenues Surge, Lifts Annual GuidanceOctober 29, 2024 | finance.yahoo.comGeneDx Shares Skyrocket 50% Today on Profit Milestone and Surge in Genomic GrowthOctober 29, 2024 | finance.yahoo.comGeneDx (NASDAQ:WGS) Reaches New 52-Week High - What's Next?GeneDx (NASDAQ:WGS) Hits New 12-Month High - Should You Buy?October 29, 2024 | marketbeat.comGeneDx (NASDAQ:WGS) Shares Down 3% - Here's WhyGeneDx (NASDAQ:WGS) Shares Down 3% - Time to Sell?October 28, 2024 | marketbeat.comGeneDx Q3 2024 Earnings PreviewOctober 28, 2024 | msn.comAssenagon Asset Management S.A. Sells 37,040 Shares of GeneDx Holdings Corp. (NASDAQ:WGS)Assenagon Asset Management S.A. cut its position in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 10.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 329,256 shares of the compaOctober 27, 2024 | marketbeat.comGeneDx reveals new findings from newborn genetic screening studyOctober 25, 2024 | finance.yahoo.comGeneDx price target raised to $70 from $46 at Craig-HallumOctober 24, 2024 | markets.businessinsider.comCraig-Hallum Remains a Buy on GeneDx Holdings (WGS)October 24, 2024 | markets.businessinsider.comCraig Hallum Boosts GeneDx (NASDAQ:WGS) Price Target to $70.00Craig Hallum lifted their price target on GeneDx from $46.00 to $70.00 and gave the stock a "buy" rating in a research note on Thursday.October 24, 2024 | marketbeat.comGeneDx (WGS) to Release Quarterly Earnings on TuesdayGeneDx (NASDAQ:WGS) will be releasing earnings before the market opens on Tuesday, October 29, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=633060)October 22, 2024 | marketbeat.comGeneDx (NASDAQ:WGS) Shares Up 5.9% - Time to Buy?GeneDx (NASDAQ:WGS) Shares Up 5.9% - What's Next?October 18, 2024 | marketbeat.comThe Manufacturers Life Insurance Company Buys Shares of 11,102 GeneDx Holdings Corp. (NASDAQ:WGS)The Manufacturers Life Insurance Company purchased a new position in shares of GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 11,102 shares of theOctober 18, 2024 | marketbeat.com Get GeneDx News Delivered to You Automatically Sign up to receive the latest news and ratings for WGS and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump said you could learn something from this man (Ad)Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement. Here’s everything you need to know. WGS Media Mentions By Week WGS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. WGS News Sentiment▼0.440.45▲Average Medical News Sentiment WGS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. WGS Articles This Week▼174▲WGS Articles Average Week Get GeneDx News Delivered to You Automatically Sign up to receive the latest news and ratings for WGS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies HIMS News Today SHC News Today GH News Today OPCH News Today BTSG News Today VCYT News Today SGRY News Today LFST News Today CON News Today PACS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:WGS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GeneDx Holdings Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share GeneDx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
